Category:

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of RCL, MESO and LVS

The MarketWatch News Department was not involved in the creation of this content.

December 03, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / December 3, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Royal Caribbean Cruises Ltd. (NYSE:RCL)Class Period: February 4, 2020 – March 17, 2020Lead Plaintiff Deadline: December 7, 2020

The RCL lawsuit alleges Royal Caribbean Cruises Ltd. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) Royal Caribbean misled investors to believe that any issue related to COVID-19 was relatively insignificant; (2) the Company falsely assured investors that bookings outside China were strong

Read More
Posted On :
Category:

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MESO, TRQ and LVS

The MarketWatch News Department was not involved in the creation of this content.

December 01, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / December 1, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Mesoblast Limited (NASDAQ:MESO)

Investors Affected: April 16, 2019 – October 1, 2020

A class action has commenced on behalf of certain shareholders in Mesoblast Limited. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) comparative analyses between Mesoblast’s Phase 3 trial and three historical studies did not support the effectiveness of the Company’s

Read More
Posted On :
Category:

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of RCL, MESO and FAF

The MarketWatch News Department was not involved in the creation of this content.

December 01, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / December 1, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Royal Caribbean Cruises Ltd. (NYSE:RCL)Class Period: February 4, 2020 – March 17, 2020Lead Plaintiff Deadline: December 7, 2020

The RCL lawsuit alleges that Royal Caribbean Cruises Ltd. made materially false and/or misleading statements and/or failed to disclose that: (1) Royal Caribbean misled investors to believe that any issue related to COVID-19 was relatively insignificant; (2) the Company falsely assured investors that bookings outside China were strong with no signs

Read More
Posted On :
Category:

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MESO, LOOP and TILE

The MarketWatch News Department was not involved in the creation of this content.

November 30, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / November 30, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Mesoblast Limited (NASDAQ:MESO)

Investors Affected: April 16, 2019 – October 1, 2020

A class action has commenced on behalf of certain shareholders in Mesoblast Limited. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) comparative analyses between Mesoblast’s Phase 3 trial and three historical studies did not support the effectiveness of the

Read More
Posted On :
Category:

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MESO, BABA and PINS

The MarketWatch News Department was not involved in the creation of this content.

November 30, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / November 30, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Mesoblast Limited (NASDAQ:MESO)Class Period: April 16, 2019 – October 1, 2020Lead Plaintiff Deadline: December 7, 2020

Mesoblast Limited allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) comparative analyses between Mesoblast’s Phase 3 trial and three historical studies did not support the effectiveness of the Company’s lead product candidate, remestemcel-L, for steroid refractory acute graft versus host disease due to design differences between the four

Read More
Posted On :
Category:

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MESO, LOOP and LRN

The MarketWatch News Department was not involved in the creation of this content.

November 23, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / November 23, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Mesoblast Limited (NASDAQ:MESO)Class Period: April 16, 2019 – October 1, 2020Lead Plaintiff Deadline: December 7, 2020

Mesoblast Limited allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) comparative analyses between Mesoblast’s Phase 3 trial and three historical studies did not support the effectiveness of the Company’s lead product candidate, remestemcel-L, for steroid refractory acute graft versus host disease due to design differences between the four

Read More
Posted On :
Category:

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MESO, RTX and BIIB

The MarketWatch News Department was not involved in the creation of this content.

November 18, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / November 18, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Mesoblast Limited (NASDAQ:MESO)

Investors Affected: April 16, 2019 – October 1, 2020

A class action has commenced on behalf of certain shareholders in Mesoblast Limited. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) comparative analyses between Mesoblast’s Phase 3 trial and three historical studies did not support the effectiveness of the

Read More
Posted On :

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOCO, TCMD and MESO

The MarketWatch News Department was not involved in the creation of this content.

November 11, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / November 11, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

GoHealth, Inc. (NASDAQ:GOCO)The GoHealth lawsuit is on behalf of all purchasers of GoHealth Class A common stock pursuant and/or traceable to the registration statement issued in connection with GoHealth’s July 2020 initial public offering.Lead Plaintiff Deadline: November 20, 2020

The complaint alleges that throughout the class period GoHealth, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Medicare insurance industry was undergoing a period

Read More
Posted On :
Category:

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MESO, LOOP and FAF

The MarketWatch News Department was not involved in the creation of this content.

November 11, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / November 11, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Mesoblast Limited (NASDAQ:MESO)

Investors Affected: April 16, 2019 – October 1, 2020

A class action has commenced on behalf of certain shareholders in Mesoblast Limited. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) comparative analyses between Mesoblast’s Phase 3 trial and three historical studies did not support the effectiveness of the

Read More
Posted On :